Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8440594 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
M-EI regimen/strategy was feasible for patient aged â¤25 years with survival rates are comparable to those obtained with MAP regimen.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nathalie Gaspar, Bob-Valéry Occean, Hélène Pacquement, Emmanuelle Bompas, Corine Bouvier, Hervé J. Brisse, Marie-Pierre Castex, Nadir Cheurfa, Nadège Corradini, Jessy Delaye, Natacha Entz-Werlé, Jean-Claude Gentet, Antoine Italiano, Cyril Lervat,